Further to the announcement of a new chair and co-chair for the English National Section we are delighted to announce that Gill Pope, Lecturer at the University of Central lancshire (UCLAN) will be taking on the role of second co-chair. This will strengthen the research and innovation aspect of the section.
After 9 years of supporting E-P-A in the role of office and membership manager, Alexandra Pardon has chosen a new career pathway. We thank Alexandra for her work over the last years in promoting and supporting the association, and the activities such as master classes and conferences. From March 1st, 2017 the role of Office manager will be taken over by Ellen Coeckelberghs, PhD. Ellen is a postdoctoral researcher at the Leuven Institute for Healthcare Policy with a special interest in care pathway research. We’re very happy to have Ellen on board!
One of the first items on Ellens’ to do list, is the organisation of the International master class on Care Pathways in September this year. For more information and registration, see Concerences and Courses
The E-P-A Bureau
As of this year, the E-P-A section for England will be chaired by John Salter, and co-chaired by Karen Green. John and Karen introduce themselves and the plans for the future. Read more
The 3-day international master class on care pathways and organisation of care processes will be organised from September 21-23, 201 in Venice, Italy. The master class will focus on care pathways in relation to other current topics such as Pathways for Health and Value Based Healthcare. This should be more than only jargon or some words in your mission statement. But how can you bring this value in your daily organisation of care? That is the challenge for this master class.
In September 2017 E-P-A will organize a 3 day international summer school on Care Pathways and Management of Care Processes. More info soon!
The Care Process Self-Evaluation Tool (CPSET) for the first time in a Nordic language
Many E-P-A members and care pathway developers are familiar with the Care Process Self-Evaluation Tool (CPSET), which ten years ago was developed by researchers at the KU Leuven in Belgium and validated in the Belgian–Dutch Clinical Pathway Network in cooperation with the European Pathway Association (E-P-A) (Vanhaecht et al. 2007). Read more
For a research project on “care pathways for patients with low back pain” we are looking for international expertise in this area. Low back pain is a common problem, with a lifetime prevalence of up to 80%, which results in a tremendous cost for society in terms of direct medical costs and costs from loss of productivity. Moreover, the condition is characterized by a tendency for over-medicalisation and medical overconsumption. Therefore, we want to investigate what lessons can be learned from the care pathways organized elsewhere to manage low back pain and limit its impacts.
November 28, 2015 |The Bram & Bluma Appel Salon at the Toronto Reference Library
The inaugural pathways conference was held this past November to an audience of doctors, nurses, clinicians, pharmacists, and various other medical professionals and mental health and addiction specialists.
This week, a group of 12 professional graduated from the 10-day Care Pathway Course, in Utrecht, the Netherlands. This course is organised within the Belgian-Dutch Clinical Pathway Network. The 7-phase model forms the backbone of the course. The 10 days are spread over a period of just over a year, in which the participants perform a care pathway project. The course ends with (poster) presentations on the projects, showing results and lessons learned.
In E-P-A newsletter Issue 12, November 2013, we informed you of a project aimed at developing and implementing care pathways for nutrition problems. It is now time to give you a quick update. The project, supported by an unconditional educational grant by Baxter, is executed in 3 hospitals in Belgium, France, Germany and The Netherlands, and is a good example of working with a care pathway as a complex intervention. A complex intervention is always a combination of several ‘active ingredients’. In the case of care pathways these ingredients are: 1) the evidcence based key interventions and indicators for the target group; 2) feedback on the current care process on the basis of the key indicators; and 3) an improvement strategy to improve the care process.
So far, we have produced an overview of evidence based interventions and indicators by performing a systematic review. An international expert panel validated the output. A formal publication of the systematic review is under review with in the research team.
The 12 participating hospitals have performed a retrospective patient record analysis to provide data on the current care process. This has resulted in a 140 page feedback report, which can be used as a benchmark. We have organized feedback sessions per country for the participating teams, where we shared the results. Some of the results, such as time between decision for surgery and surgery, or number of patients that where screened for malnutrition, were real eye-openers for the teams, indicating room for improvement.
The next phase of the project is the quality improvement strategy (active ingredient #3) which is planned for the next few months. After this, the teams will perform a prospective analysis, to see if their performance has improved.
We will keep you posted!
The CP4NutriGICan research team,
Ruben van Zelm, MSc; Prof. Kris Vanhaecht (principal investigator); Ellen Coeckelberghs, PhD; Prof. Massimiliano Panella; Prof. Walter Sermeus
Lead contact person for Baxter: mrs. L. Nonneman
ST- Elevation Myocardial infarction (STEMI) is one of the most common disease in our aging world that leads to mortality due to its time sensitivity characteristics. The promises by clinical pathway in controlling the cost, time and quality of patient care has encouraged the use of clinical pathway in STEMI care. However, it is still not clear what are the the most optimal clinical pathway components that will suit the STEMI patients and will make the use of the clinical pathway more practical?. Hence, in this study a survey was designed to answer the aforementioned question.